DOCSLIB.ORG

Leveraging the Power of Materials to Change the World

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Leveraging the Power of Materials to Change the World Toray Group CSR Report 2015 Leveraging the Power of Materials to Change the World Focusing on Innovation and Challenge 2 Contents CSR TOP -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------01 Editional Policy -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------03 Message from the President -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------05 Special Feature -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------06 Green Innovation in the Environment and Energy Field---------------------------------------------------------------------------------------------------------------------------------------------------------------------06 1. Reducing CO2 emissions------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------08 2. Tackling Energy Issues---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------10 3. Addressing Environmental Changes----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------12 Life Innovations in the Medical and Healthcare Field -----------------------------------------------------------------------------------------------------------------------------------------------------------------------14 1. Improving the quality of medical care --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------16 2. Reducing burden on medical staff ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------18 3. Contributing to health maintenance and longevity----------------------------------------------------------------------------------------------------------------------------------------------------------------19 Empowering Women -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------20 Toray Group's Corporate Social Responsibility---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------22 Toray Group's Management Philosophy and CSR---------------------------------------------------------------------------------------------------------------------------------------------------------------------------23 Toray Group's Management Strategies and CSR----------------------------------------------------------------------------------------------------------------------------------------------------------------------------25 "Working Comprehensively on Social Responsibility, Management Philosophy and Management Strategy" "Organizational Structure for Social Responsibility"----------------------------26 "Social Responsibility at Toray Group" "Progress on Key Performance Indicators in Fiscal 2014" -------------------------------------------------------------------------------------------------------------27 Materiality at Toray Group----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------28 Fifth CSR Road Map (Fiscal 20142016)----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------29 Value Creation -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------30 Contributing Solutions to Social Issues through Business Activities Management-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------31 Green Innovation Business Expansion Project -----------------------------------------------------------------------------------------------------------------------------------------------------------------------32 Promoting Life Cycle Management --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------33 Approach to Green Innovation Product Sector ------------------------------------------------------------------------------------------------------------------------------------------------------------------------34 Promoting Recycling Initiatives -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------36 Life Innovation Business Expansion Project---------------------------------------------------------------------------------------------------------------------------------------------------------------------------39 Governance -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------41 Corporate Governance and Management Transparency Management--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------42 Implementing CSR Activities and Improving CSR Education ------------------------------------------------------------------------------------------------------------------------------------------------------44 Corporate Ethics and Legal Compliance Management-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------46 Corporate Ethics, Regulatory Infractions, and Recurrence Prevention-----------------------------------------------------------------------------------------------------------------------------------------47 Ensuring Employees Understand the Importance of Ethical Conduct and Legal Compliance ------------------------------------------------------------------------------------------------------------48 Improving Training Related to Security Trade Controls -------------------------------------------------------------------------------------------------------------------------------------------------------------50 Compliance with Antitrust Laws and Anti-Bribery Rules around the World-------------------------------------------------------------------------------------------------------------------------------------50 Protection of Personal Information----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------50 Disclosure of Information Regarding the Ethical Treatment of Laboratory Animals--------------------------------------------------------------------------------------------------------------------------51 Risk Management Management--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------52 Risk Management System and Initiatives-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------53 Security Trade Control -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------55 Business Continuity Plan Initiatives---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------55 Social Initiatives -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------56
Load more

Recommended publications
  • Daiichi Sankyo Company, Limited
    [Translation] CONVOCATION NOTICE OF THE 6TH ORDINARY GENERAL MEETING OF SHAREHOLDERS For the Fiscal Period Ended March 31, 2011 Daiichi Sankyo Company, Limited - 1 - [Translation] (Securities Identification Code 4568) May 31, 2011 To Shareholders, Daiichi Sankyo Company, Limited Joji Nakayama, Representative Director and President & CEO 5-1, Nihonbashi Honcho 3-chome, Chuo-ku, Tokyo, Japan CONVOCATION NOTICE OF THE 6TH ORDINARY GENERAL MEETING OF SHAREHOLDERS We wish to extend our deepest sympathy to all those who have suffered hardship from the Great East Japan Earthquake that occurred in March 2011. Daiichi Sankyo Company, Limited (“the Company”) respectfully requests your attendance at the 6th Ordinary General Meeting of Shareholders (“the Meeting”), which will be held as detailed below. If you will not be able to attend the Meeting, you may exercise your voting rights through either of the methods described below, in which case we ask that you please exercise your voting rights by 17:30 (within our business hours), Friday, June 24, 2011 (Japan Time), after examining the attached reference documents. [Exercise of Voting Rights by Mail] Please indicate your approval or disapproval for the proposals on the enclosed voting form and return the form to the Company. Please note that the form must be received by the Company no later than the above-mentioned deadline. [Exercise of Voting Rights on the Internet etc.] After examining “Information on Exercise of Voting Rights, etc.” on pages 57 and 58, please vote on the Internet at the dedicated voting website (http://www.evote.jp/) no later than the above-mentioned deadline. The Company is participating in the platform for electronic exercise of voting rights for institutional investors operated by ICJ Inc.
    [Show full text]
  • CSR Report 2009
    Locations Head Office 16-5, Konan 2-chome, Minato-ku, Tokyo Postal Code: 108-8215 Phone: 81-3-6716-3111 (main number) Fax: 81-3-6716-5800 Headquarters and Divisions General Machinery & Special Vehicle Headquarters 3000, Tana, Sagamihara, Kanagawa Postal Code: 229-1193 Phone: 81-42-761-1101 (General Affairs Dept.) Fax: 81-42-763-0800 Air-Conditioning & Refrigeration Systems Headquarters 3-1, Asahi, Nishi-biwajima-cho, Kiyosu, Aichi Postal Code: 452-8561 Phone: 81-52-503-9200 (General Affairs Dept.) Fax: 81-52-503-3533 Paper & Printing Machinery Division 1-1-1, Itozaki-Minami, Mihara, Hiroshima Postal Code: 729-0393 Phone: 81-848-67-2054 (General Affairs & Labor Section) Fax: 81-848-63-4463 Machine Tool Division 130, Roku-jizo, Ritto, Shiga Postal Code: 520-3080 Phone: 81-77-553-3300 (General Affairs Dept.) Fax: 81-77-552-3745 Works Nagasaki Shipyard & Machinery Works 1-1, Akunoura-machi, Nagasaki Postal Code: 850-8610 Phone: 81-95-828-4121 (General Affairs Dept.) Fax: 81-95-828-4034 Kobe Shipyard & Machinery Works 1-1-1, Wadasaki-cho, Hyogo-ku, Kobe Postal Code: 652-8585 Phone: 81-78-672-2220 (General Affairs Dept.) Fax: 81-78-672-2245 Address all inquiries about this report to: Shimonoseki Shipyard & Machinery Works 6-16-1, Hikoshima Enoura-cho, Shimonoseki Postal Code: 750-8505 Mitsubishi Heavy Industries, Ltd. Phone: 81-83-266-5978 (General Affairs & Labor Section) Corporate Social Responsibility Department Fax: 81-83-266-8274 CSR Report 16-5, Konan 2-chome, Minato-ku, Tokyo, Japan Yokohama Machinery Works 1-8-1, Sachiura, Kanazawa-ku,
    [Show full text]
  • 2018 年度－3/31/19 現在）
    寄付ご支援を頂いた企業・団体・個人の方々は下記の通りです。 （2018 年度－3/31/19 現在） $20,000 and up_____________ Mizuho Bank, Ltd. JX Nippon Oil & Energy (Americas) Inc. MUFG Union Bank, N. A. Kaneka America Holding, Inc. SMBC Kawasaki Heavy Industries (U.S.A.), Inc. KBK Inc. $10,000 and up (under $20,000) Kowa American Corp. Kuraray America, Inc. ITOCHU International Inc. Kyocera Document Solutions America, Inc. Marubeni America Corporation Kyocera International Inc. Mitsubishi Corporation (Americas) Kyowa Hakko USA, Inc. Mitsui & Co. (U. S. A.), Inc. Mayer Brown, LLP Nomura America Foundation Mitsubishi Gas Chemical America, Inc. Sumitomo Corporation of Americas Foundation Mitsubishi Imaging (MPM), Inc. Mitsubishi UFJ Trust & Banking Corp. , NY Branch Mitsui Chemicals America, Inc. $5,000 and up (under $10,000) Mitsui Seiki (U.S.A.), Inc. Mitsui Sumitomo Marine Management (U.S.A.), Inc. J. C. C. Fund Miyoshi America, Inc. Nippon Express Foundation, Inc. Mizuho Securities USA Inc. Panasonic Corp. of North America Nikkei America, Inc. Nikko Asset Management Americas, Inc. $1,000 and up (under $5,000) Nikon Americas Inc. Nippon Life Insurance Company Alice Corporation Nippon Steel & Sumitomo Metal U. S. A., Inc. All Nippon Airways Co., Ltd. NOF America Corporation Asahi Kasei America, Inc. The Norinchukin Bank, Ltd. Asset Management One USA Inc. NTT America, Inc. Canon U. S. A., Inc. NYK Line (North America), Inc. Casio America, Inc. ORIX Corporation USA Chugai Pharma U.S.A. Inc. Osaka Gas USA Corporation Citizen Watch Company of America, Inc Relo Redac, Inc. Dainobu, USA Inc. Sapporo USA, Inc. Daiwa Capital Markets America, Inc. SCSK USA Inc. DLI North America Inc.
    [Show full text]
  • Whither the Keiretsu, Japan's Business Networks? How Were They Structured? What Did They Do? Why Are They Gone?
    IRLE IRLE WORKING PAPER #188-09 September 2009 Whither the Keiretsu, Japan's Business Networks? How Were They Structured? What Did They Do? Why Are They Gone? James R. Lincoln, Masahiro Shimotani Cite as: James R. Lincoln, Masahiro Shimotani. (2009). “Whither the Keiretsu, Japan's Business Networks? How Were They Structured? What Did They Do? Why Are They Gone?” IRLE Working Paper No. 188-09. http://irle.berkeley.edu/workingpapers/188-09.pdf irle.berkeley.edu/workingpapers Institute for Research on Labor and Employment Institute for Research on Labor and Employment Working Paper Series (University of California, Berkeley) Year Paper iirwps-- Whither the Keiretsu, Japan’s Business Networks? How Were They Structured? What Did They Do? Why Are They Gone? James R. Lincoln Masahiro Shimotani University of California, Berkeley Fukui Prefectural University This paper is posted at the eScholarship Repository, University of California. http://repositories.cdlib.org/iir/iirwps/iirwps-188-09 Copyright c 2009 by the authors. WHITHER THE KEIRETSU, JAPAN’S BUSINESS NETWORKS? How were they structured? What did they do? Why are they gone? James R. Lincoln Walter A. Haas School of Business University of California, Berkeley Berkeley, CA 94720 USA ([email protected]) Masahiro Shimotani Faculty of Economics Fukui Prefectural University Fukui City, Japan ([email protected]) 1 INTRODUCTION The title of this volume and the papers that fill it concern business “groups,” a term suggesting an identifiable collection of actors (here, firms) within a clear-cut boundary. The Japanese keiretsu have been described in similar terms, yet compared to business groups in other countries the postwar keiretsu warrant the “group” label least.
    [Show full text]
  • Company Title Work Country Aksa Akrilik Kimya Sanayii A.S General Manager & Board Member Turkey Marketing, Sales & New Business Aksa Akrilik Kimya Sanayii A.S
    Company Title Work Country Aksa Akrilik Kimya Sanayii A.S General Manager & Board Member Turkey Marketing, Sales & New Business Aksa Akrilik Kimya Sanayii A.S. Turkey Development Director Aksa Akrilik Kimya Sanayii A.S. Raw Materials Supply Chain Executive Turkey AnQore B.V. CEO Netherlands AnQore B.V. Sr. Product Sales Manager Netherlands AnQore B.V. Director Marketing & Sales Netherlands Apcotex Industries Limited DGM-Sourcing India Apcotex Industries Limited DGM-Procurement India Arlanxeo Deutschland GmbH Director Procurement Germany Asahi Kasei Corporation Senior General Manager Japan Asahi Kasei Corporation Lead Executive Officer Japan Asahi Kasei Corporation Manager Japan Asahi Kasei Corporation Assistant Manager South Korea Asahi Kasei Corporation General Manager South Korea Asahi Kasei Corporation Manager South Korea Ascend Performance Materials AN Product Manager USA Ascend Performance Materials Global Business Director Chemicals USA Bangkok Synthetics Co.,Ltd. Procurement Engineer Thailand BASF Procurement Manager China BASF (China) Co., Ltd. Senior Manager China BASF SE Director Basic Chemicals Germany BASF SE Global buyer Germany Black Rose Industries Ltd. Executive Director India Bloomberg News Reporter Singapore Braskem Account Manager Brazil Information & System Integration Chemical Logitec Co., Ltd. Japan Department Chemicals Planning Dept. Chemicals Management Group Japan China Petrochemical Development Specialist Taiwan Corporation CJ Bio Malaysia Sdn Bhd CEO Malaysia Cornerstone Chemical Co. CEO USA Cornerstone Chemical
    [Show full text]
  • April 18, 2007 Press Release Ajinomoto Co., Inc. Eisai Co., Ltd
    April 18, 2007 Press Release Ajinomoto Co., Inc. Eisai Co., Ltd. Takeda Pharmaceutical Company Limited A ONCE-WEEKLY FORMULATION OF RISEDRONATE SODIUM HYDRATE, AN ANTIOSTEOPOROTIC AGENT, WAS APPROVED. Ajinomoto Co., Inc. (“Ajinomoto”, President and CEO: Norio Yamaguchi, Headquarters: Tokyo) and Takeda Pharmaceutical Company Limited (“Takeda”, President: Yasuchika Hasegawa, Headquarters: Osaka) are pleased to announce that the Ministry of Health, Labour and Welfare approved today “ActonelⓇ 17.5 mg tablets” and “BenetⓇ 17.5 mg tablets”, a once-weekly formulation of risedronate sodium hydrate (generic name) for the treatment of osteoporosis. Both Ajinomoto and Takeda own the drug manufacturing approval of above products while Eisai Co., Ltd. (“Eisai”, President and CEO: Haruo Naito, Headquarters: Tokyo) will distribute “ActonelⓇ 17.5 mg tablets” supplied by Ajinomoto, and Takeda will distribute “BenetⓇ 17.5 mg tablets” respectively. Risedronate sodium hydrate is a bisphosphonate antiosteoporotic agent, which was originally synthesized by Norwich Eaton Pharmaceuticals, Inc. in the United States (then a subsidiary of The Procter & Gamble Company and now Procter & Gamble Pharmaceuticals, Inc.). This agent has two distinctive features from other antiosteoporotics: In the additional analysis of large clinical trials, vertebral and non-vertebral bone fractures suppressing effects of this agent showed statistically significant difference as compared to placebo as early as 6 months after starting administration. In large clinical trials with the primary endpoint of the reduction of frequency of hip fractures, this agent showed statistically significant difference as compared to placebo. The once-weekly formulation of risedronate sodium hydrate was approved in 2002 in the United States and now are being approved in more than 80 countries around the world.
    [Show full text]
  • Mizuho Financial Group, Inc
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ‘ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR È ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2016 OR ‘ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ‘ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report For the transition period from to Commission file number 001-33098 Kabushiki Kaisha Mizuho Financial Group (Exact name of Registrant as specified in its charter) Mizuho Financial Group, Inc. (Translation of Registrant’s name into English) Japan (Jurisdiction of incorporation or organization) 1-5-5 Otemachi Chiyoda-ku, Tokyo 100-8176 Japan (Address of principal executive offices) Masahiro Kosugi, +81-3-5224-1111, +81-3-5224-1059, address is same as above (Name, Telephone, Facsimile number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act. Title of each class Name of each exchange on which registered Common Stock, without par value The New York Stock Exchange* American depositary shares, each of which represents two shares of The New York Stock Exchange common stock Securities registered or to be registered pursuant to Section 12(g) of the Act. None (Title of Class) Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report.
    [Show full text]
  • Fact Sheet on Recent Developments in Japan-UK Business Relations
    April 2012 Ministry of Foreign Affairs of Japan, West Europe Division Fact Sheet on Recent Developments in Japan-UK Business Relations 1 Overview (1) Close investment relationship between Japan and the UK ○The UK is the fourth-largest source of EU investment in Japan (¥765bn in 2010). ○The UK is Japan’s second-largest investment destination in the EU (¥3.09 trillion in 2010). [stock; Source: Bank of Japan] ○In FY2010, Japan was the world’s no. 2 source of project-based investment in the UK (105 projects). [Source: UKTI] ○The EU is the world’s largest source of direct investment in Japan (approx. ¥6.7 trillion). ○Japan is the world’s third-largest source of direct investment in the EU (approx. ¥15 trillion). [2010; Source: Bank of Japan] (2) UK direct investment in Japan surpassed investment in the reverse direction in 2009 and 2010 but the situation reversed in 2011. ○UK→JPN (¥527.7bn in 2009; ¥417.1bn in 2010; ¥146.0bn in 2011) ○JPN→UK (¥204.5bn in 2009; ¥385.5bn in 2010; ¥1.12 trillion in 2011). [Source: Bank of Japan and Ministry of Finance] (3) Japanese corporations’ contribution to employment in the UK ○As many as 1, 272 Japanese companies are operating in the UK. As of 2010, they had created over 130,000 jobs. [Source: (the number of companies) MOFA, (the number of employees) METI, the survey of overseas business activities (based on the 469 companies that responded)] 2 Examples of British investment in Japan [Development and manufacture of vehicles and fuel cells] ○Intelligent Energy Holdings In February 2012, the company established a joint-venture enterprise, Smile FC System Corporation, with Suzuki Motor Corporation for the development and manufacture of fuel cells.
    [Show full text]
  • Takeshi Nakao
    Takeshi Nakao Partner Corporate and M&A He has solid knowledge and experience in a variety of local Japanese law topics that are involved in cross-border M&A transactions. Chambers Asia-Pacific 2021 Primary practice Corporate and M&A 29/09/2021 Takeshi Nakao | Freshfields Bruckhaus Deringer About Takeshi Nakao <p><strong>Takeshi is the managing partner of our Tokyo office and the head of our Japan practice. He specialises in cross-border M&amp;A, private equity, joint ventures and general corporate matters.</strong></p> <p>Takeshi advises corporates on both outbound and inbound transactions. He has advised companies wanting to move into Europe, US, Asia and into countries as far flung as Africa.</p> <p>He also has extensive experience advising on various antitrust law issues in relation to M&amp;A activities, including merger-control filings and analysis, and various commercial arrangements.</p> <p>His knowledge of Japanese law, whether or not it is used on a transaction, is a great comfort to his Japanese clients.</p> <p>Takeshi is a lecturer at Hitotsubashi University School of Law, where he teaches on world business law.</p> <p>Takeshi speaks Japanese and English.</p> Recent work <ul> <li>Advising Knorr-Bremse on its acquisition of Hitachi's integral power steering business for commercial vehicles in Japan and Thailand.</li> <li>Advising Ajinomoto, Japan's largest food company, on its $532m acquisition of a 33.33 per cent stake in Promasidor, a major seasonings and processed foods manufacturer that operates in 36 African countries. <a href="../../../../../../link/41249fa8cd93414aa9fd412e02d7a233.aspx" target="_blank" rel="noopener">Read more about the deal in our case study</a>.</li> <li>Advising Marubeni Corporation on its acquisition of a 60 per cent stake in Olympus Holding B.V.
    [Show full text]
  • Organization (As of July 1, 2020)
    Management system Organization (As of July 1, 2020) Corporate Strategic Planning Division Representative from Overseas General Administration & Communications Division President and Representative Board of Member of the Board, Legal & Compliance Division Directors Representative Member of the Board Human Resources Division Finance & Controller’s Division Executive Committee Quality Assurance Division Auditing Dept. Board of Intellectual Property Division Corporate Corporate Auditors Auditors Information Systems Division Purchasing & Logistics Division Corporate Auditors Office Corporate Marketing Planning Dept. Global Environment Business Strategic Planning Dept. Life Innovation Business Strategic Planning Dept. Branches Affiliated Companies Division Fibers & Textiles Division Resins & Chemicals Division Films Division Torayca & Advanced Composites Division Electronic & Information Materials Division Pharmaceuticals & Medical Products Division Water Treatment & Environment Division Technology Center Manufacturing Division Engineering Division Research & Development Division Toray Industries, Inc. Integrated Annual Report 2020 51 Members of the Board and Corporate Auditors (As of June 23, 2020) President and Representative Member of the Board Representative Member of the Board Akihiro Nikkaku Yukichi Deguchi Representative Member of the Board Mitsuo Ohya Representative Member of the Board Koichi Abe Member of the Board Masahiko Okamoto Member of the Board Satoru Hagiwara Member of the Board Minoru Yoshinaga Member of the Board Kazuyuki
    [Show full text]
  • EA Pharma Filed Marketing Approval Application for AJM300 (Nonproprietary Name: Carotegrast Methyl) Indicated for Treatment of Ulcerative Colitis
    May 28, 2021 EA Pharma Co., Ltd. Kissei Pharmaceutical Co., Ltd. (Code 4574, Tokyo Stock Exchange 1st Section) EA Pharma Filed Marketing Approval Application for AJM300 (Nonproprietary Name: Carotegrast Methyl) Indicated for Treatment of Ulcerative Colitis EA Pharma Co., Ltd. (President, Yuji Matsue; Headquarters, Chuo-ku, Tokyo, Japan; “EA Pharma”) and Kissei Pharmaceutical Co., Ltd. (Head Office: Matsumoto, Nagano; Chairman and CEO: Mutsuo Kanzawa; "Kissei") announced that EA Pharma has filed the marketing approval application in Japan for AJM300 (nonproprietary name: carotegrast methyl), which the two companies have developed for treatment of ulcerative colitis. The application was filed based on the results of Phase III clinical study (AJM300/CT3) and other studies conducted in Japan. Detailed data of AJM300/CT3 will be presented at an upcoming major medical conference this year. AJM300 is an orally available small molecule α4 integrin antagonist that was originated by EA Pharma (formerly known as Ajinomoto Pharmaceuticals Co., Ltd.). EA Pharma and Kissei have jointly developed AJM300 since 2015, aiming to launch the world-first orally available α4 integrin antagonist onto the market. In ulcerative colitis, lymphocytes and other inflammatory cells excessively aggregate and invade into the inflamed site in the colonic mucosa. AJM300 can antagonize both α4β1 and α4β7 integrins expressed on the surface of inflammatory cells and inhibit the cell adhesion mediated by binding to adhesion molecules excessively expressed on the vascular endotherial cells in the colonic mucosa, which suppresses invasion of lymphocytes into the inflamed site to exert anti-inflammation effects. EA Pharma and Kissei strive to quickly provide AJM300 for clinical use to increase treatment options for ulcerative colitis to contribute to QOL of patiens and their families.
    [Show full text]
  • Hitachi and Toray to Test "Mega-Ton Water System," a Large-Scale, High Efficiency Seawater Desalination System, In
    FOR IMMEDIATE RELEASE Hitachi and Toray to Test “Mega-ton Water System,” a Large-scale, High Efficiency Seawater Desalination System, in Saudi Arabia MOU completed with Saline Water Conversion Corporation, a Saudi Government owned seawater desalination company and Abunayyan Trading Company. Tokyo, Japan, May 20, 2015 --- Hitachi, Ltd. (TSE: 6501, “Hitachi”) and Toray Industries, Inc. (TSE: 3402, “Toray”) today announced that on May 5, a “Mega-ton Water Team” formed by the two companies completed a Memorandum of Understanding (“MOU”) regarding the testing of a “Mega-ton Water System,” which is a large-scale, high efficiency seawater desalination system. The MOU was completed in Riyadh, in the Kingdom of Saudi Arabia, with Saline Water Conversion Corporation (“SWCC”), a Saudi Government owned seawater desalination company, and Abunayyan Trading Company Limited (“ATC”), a water and energy related company, also in Saudi Arabia. On May 19, Hitachi and Toray reported on the completion of the MOU to representatives of the Japanese and Saudi governments and other interested parties at the 15th Saudi Arabia-Japan Business Council (a ceremony celebrating the 60th anniversary of the start of diplomatic relations between the two countries) held at the Hotel Okura in Minato Ward, Tokyo. The MOU stipulates that SWCC, the Mega-ton Water Team, and ATC will collaborate in the promotion and implementation of activities targeting tests using Mega-ton Water System technologies. Through these tests, the three signing parties will strive to achieve early startup of the Mega-ton Water System, which will produce one million cubic meters of fresh water per day from sea water at low costs, and with low energy consumption and minimal environmental impact.
    [Show full text]